Arvind Thiagarajan
CEO of HD Stethoscope
Arvind Thiagarajan is the Founder & CEO of HD Medical Inc. He is an inventor and entrepreneur with a history of founding, advising, and building technology companies. Arvind was given a special award from Member of Parliament for Science and Technology from the Government of India for his contributions to research and science and his work as part of HD Medical won the Socially Relevant Product (SRP) award in IIT Madras. His inventions have helped in screening thousands of children and people in India and worldwide. The HD Medical products invented by Arvind have been used to screen over 100,000 children in India to detect cardiac murmurs and defects. This resulted in the early detection and timely intervention to save close to 100 children’s lives so far.
His second invention, a data compression technology called ABO (Adaptive Binary Optimization) at MatrixView was chosen as the "Top 5 evolving technologies" by CNBC Asia and also named twice the Frost & Sullivan "Best Technology Award" for medical imaging. Hundreds of hospitals worldwide use MatrixView’s technology for solving storage and transmission issues. Arvind took MatrixView Public in the Australian Stock Exchange (ASX), and the stock price went up to almost $250 Million market cap value at its peak.
Arvind is also a Founding Trustee and Director of Heart to Heart Foundation, which supports the Free Heart surgeries of underprivileged children in India. He also volunteers for SAI Global Mission Foundation which is focused on Societal Advancement Initiatives for providing Free Healthcare, Education and Nutrition to underserved communities worldwide.
Arvind was mentored by Dr. APJ Abdul Kalam, the former President of India. He graduated from the College of Engineering, Guindy part of the Anna University in India with an engineering degree in Electronics and Communications. Arvind specializes in signal processing and algorithm development with multiple granted and pending patents along with several award winning technical publications under his name.
Regula Schegg
Managing Director, Asia at Circulate Capital
Regula is Managing Director, Asia at Circulate Capital. She leads the investment strategy, manages the investment team, and oversees Circulate Capital Ocean Fund’s investment portfolio in South and Southeast Asia. Together with her team, Regula manages asset allocations as well as due diligence, portfolio management of fund investments. She also provides strategic advisory to the portfolio companies, focusing on strategy, business development, fundraising, key hiring decisions, financial management and governance.
Regula is an experienced global professional with over 20 years of leadership, business development, project management finance and social enterprise/start-up expertise. Throughout her corporate career, she held positions in corporate strategy, M&A, private equity, financial controlling, and business development.
She was further engaged in the microfinance industry, establishing a growth guarantee fund, financing microfinancing institutions. She further established a social enterprise in the Philippines, developing sustainable housing technologies, establishing production and construction of affordable housing solutions in collaboration with urban poor communities and civil society organizations in Southeast Asia.
Regula graduated with an MBA (Honors) in Global Management from Thunderbird, School of Global Management, USA, with undergraduate studies in Switzerland, the United Kingdom and France. She is an Aspen Institute Business & Society First Movers Fellow. Regula speaks German, English and French.